Source Code And DCM Co-lead New Round In Chinese AI Pharmaceutical Firm Galixir
August 17, 2020 — 12:48 CST
This Data Is Locked!
This area is available only to Subscribers.
China’s AI drug research and development platform Galixir has secured nearly US$10 million in a Pre-A round financing co-led by Source Code Capital and DCM.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals